EpiVax Seminars in Tokyo
September 25-26, 2025 | The Westin Hotel, Meguro, Tokyo
EpiVax is hosting two back-to-back seminars in one of our favorite cities: Tokyo, Japan. Join us on Thursday for the Westin Immunogenicity Seminar, on Friday for the Tregs as Medicine Workshop, or both! As always, participation is free of cost and will include networking receptions at the close of each seminar. Each event will feature a thoughtfully curated agenda of expert talks, networking opportunities with leading immunologists and biotech professionals, poster presentations, a key takeaway panel, and more.
*Please note: these are in-person seminars with no option for virtual attendance.
The 17th annual Westin Immunogenicity Seminar
September 25, 2025 | 9:00 am – 5:00 pm | The Westin Hotel, Meguro, Tokyo
The Westin Immunogenicity Seminar is a unique forum for industry leaders to exchange ideas, present research updates, and connect with potential collaborators. The seminar’s mission is to bridge the gap between biologic and vaccine development and the latest research advancements in immunogenicity.
Organizing Committee:
Annie De Groot, MD Founder & CSO, EpiVax Inc.
Susumu Uchiyama, PhD Professor, Department of Biotechnology, Osaka University
Takuya Tsunoda, MD Professor, Medical Oncology, Showa University
Hiroki Shirai, PhD Coordinator, RIKEN Center for Computational Science. Visiting Professor, Faculty of Pharmaceutical Sciences, Kumamoto University.
Vibha Jawa, PhD Executive Director, Biotherapeutics and Bioanalysis, Bristol Myers Squibb
Jochem Gokemeijer, PhD Distinguished Scientist, Biologics, Johnson & Johnson
Explore past year’s seminars!
Confirmed speakers:
Vibha Jawa, PhD Executive Director, Biotherapeutics and Bioanalysis, Bristol Myers Squibb
Guilhem Richard, PhD Chief Technology Officer, EpiVax Inc.
Susumu Uchiyama, PhD Professor, Department of Biotechnology, Osaka University
…And many more to be announced soon!
Tregs as Medicine Workshop
September 26, 2025 | 9:00 am – 5:00 pm | The Westin Hotel, Meguro, Tokyo
The Tregs as Medicine Workshop will bring together leading scientists and clinicians to examine how regulatory T cells (Tregs) and tolerance mechanisms can shape the future of biologics and vaccines. This year’s program will feature new insights into the growing role of Tregs, including a keynote from Dr. Shimon Sakaguchi on the therapeutic potential of targeting Tregs in cancer and autoimmunity. Additional presentations will explore advances in immune profiling and antigen processing, among many more, that deepen our understanding of tolerance pathways and their translational impact.
Organizing Committee:
Annie De Groot, MD Founder & CSO, EpiVax Inc.
Cevayir Coban, PhD Institute of Medical Science, Department of Microbiology and Immunology, Division of Malaria Immunology, University of Tokyo
Vibha Jawa, PhD Executive Director, Biotherapeutics and Bioanalysis, Bristol Myers Squibb
Jochem Gokemeijer, PhD Distinguished Scientist, Biologics, Johnson & Johnson
Confirmed Speakers:
Ken Ishii, MD PhD Director, International Vaccine Design Center. Professor, Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo
Shimon Sakaguchi, MD PhD Principal Investigator, Osaka University
Alessandra Franco, MD PhD Adjunct Professor, Pediatrics, University of San Diego
Olaf Rötzschke, PhD Senior Principal Investigator, A*STAR Singapore
Piotr Trzonkowski, MD PhD CEO, PolTREG
… With many more to be announced soon!
